BI-1222.52

Study Sponsor: Boehringer Ingelheim

Study Title

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

Medicine or Vaccine (generic name)

olodaterol

Sponsor Identification Number

1222.52

Trial Registry Identification Number(#'s)

NCT01696058

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 3

Link to study details on the BI Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

March 2015